David Miles Meredith, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Neoplasms | 7 | 2023 | 895 | 2.370 |
Why?
|
| Glioma | 11 | 2023 | 3401 | 1.460 |
Why?
|
| Brain Neoplasms | 12 | 2023 | 8856 | 0.870 |
Why?
|
| Neural Tube | 4 | 2016 | 46 | 0.700 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 143 | 0.690 |
Why?
|
| Immunohistochemistry | 5 | 2021 | 11360 | 0.670 |
Why?
|
| Pathology, Surgical | 1 | 2020 | 155 | 0.650 |
Why?
|
| Retinoblastoma | 1 | 2021 | 316 | 0.650 |
Why?
|
| Supratentorial Neoplasms | 1 | 2019 | 160 | 0.630 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 275 | 0.630 |
Why?
|
| Chondroma | 1 | 2018 | 58 | 0.620 |
Why?
|
| Skull Neoplasms | 1 | 2018 | 173 | 0.580 |
Why?
|
| Facial Bones | 1 | 2018 | 201 | 0.570 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.570 |
Why?
|
| Fibroma | 1 | 2018 | 212 | 0.550 |
Why?
|
| Ependymoma | 1 | 2019 | 334 | 0.550 |
Why?
|
| Glioblastoma | 3 | 2023 | 3480 | 0.460 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 2419 | 0.460 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1363 | 0.400 |
Why?
|
| Trans-Activators | 1 | 2021 | 2927 | 0.390 |
Why?
|
| Lymphoma | 1 | 2020 | 1875 | 0.380 |
Why?
|
| NF-kappa B | 1 | 2019 | 2500 | 0.370 |
Why?
|
| Transcription Factors | 8 | 2022 | 12209 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2016 | 3622 | 0.330 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 2529 | 0.330 |
Why?
|
| Pancreas | 2 | 2013 | 1686 | 0.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2014 | 1114 | 0.260 |
Why?
|
| Proteins | 1 | 2019 | 6098 | 0.240 |
Why?
|
| Neurogenesis | 2 | 2014 | 838 | 0.240 |
Why?
|
| Central Nervous System | 2 | 2022 | 1358 | 0.240 |
Why?
|
| Chromatin | 3 | 2022 | 2931 | 0.230 |
Why?
|
| Meningioma | 2 | 2022 | 1209 | 0.220 |
Why?
|
| Meningeal Neoplasms | 2 | 2022 | 1241 | 0.220 |
Why?
|
| Lithotripsy | 1 | 2023 | 142 | 0.210 |
Why?
|
| Ribonuclease III | 2 | 2022 | 275 | 0.210 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2023 | 129 | 0.210 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2022 | 375 | 0.200 |
Why?
|
| Spinal Cord | 4 | 2016 | 1809 | 0.200 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2013 | 121 | 0.190 |
Why?
|
| Transducin | 1 | 2020 | 46 | 0.190 |
Why?
|
| World Health Organization | 2 | 2023 | 1317 | 0.190 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 98 | 0.190 |
Why?
|
| Child | 12 | 2023 | 77637 | 0.190 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 169 | 0.190 |
Why?
|
| Sarcoma | 2 | 2022 | 1898 | 0.180 |
Why?
|
| Receptor, trkB | 1 | 2020 | 125 | 0.170 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 99 | 0.170 |
Why?
|
| Facial Paralysis | 1 | 2023 | 338 | 0.170 |
Why?
|
| Transcription, Genetic | 3 | 2009 | 7719 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2023 | 4552 | 0.160 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 131 | 0.160 |
Why?
|
| Homeostasis | 1 | 2009 | 3337 | 0.160 |
Why?
|
| Aneuploidy | 1 | 2021 | 530 | 0.160 |
Why?
|
| Mitotic Index | 1 | 2018 | 172 | 0.160 |
Why?
|
| Hemangioma | 1 | 2023 | 738 | 0.150 |
Why?
|
| Lymphoma, T-Cell | 1 | 2020 | 299 | 0.150 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2018 | 84 | 0.150 |
Why?
|
| Prognosis | 7 | 2023 | 29052 | 0.150 |
Why?
|
| Humans | 37 | 2023 | 743811 | 0.150 |
Why?
|
| Chick Embryo | 4 | 2016 | 983 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2020 | 1581 | 0.150 |
Why?
|
| California | 1 | 2021 | 1402 | 0.150 |
Why?
|
| Demyelinating Diseases | 1 | 2019 | 354 | 0.140 |
Why?
|
| Young Adult | 9 | 2023 | 56392 | 0.130 |
Why?
|
| Astrocytoma | 1 | 2020 | 790 | 0.130 |
Why?
|
| Mouth Diseases | 1 | 2018 | 241 | 0.130 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2016 | 284 | 0.130 |
Why?
|
| Adolescent | 11 | 2023 | 85729 | 0.130 |
Why?
|
| Mutation | 8 | 2023 | 29777 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2022 | 1660 | 0.120 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 518 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2453 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 9731 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2023 | 40964 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2020 | 2634 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 1392 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 67 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 931 | 0.110 |
Why?
|
| Consensus Sequence | 1 | 2013 | 378 | 0.110 |
Why?
|
| Base Sequence | 6 | 2016 | 12798 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 794 | 0.110 |
Why?
|
| Adult | 11 | 2023 | 213889 | 0.110 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1345 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2018 | 1917 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 518 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1861 | 0.100 |
Why?
|
| Parietal Lobe | 1 | 2016 | 832 | 0.090 |
Why?
|
| Histones | 1 | 2020 | 2598 | 0.090 |
Why?
|
| Infant | 5 | 2023 | 35122 | 0.090 |
Why?
|
| Neural Inhibition | 1 | 2014 | 598 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 1420 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1580 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 803 | 0.090 |
Why?
|
| Cerebellum | 1 | 2016 | 1487 | 0.080 |
Why?
|
| Vision Disorders | 1 | 2016 | 1055 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.080 |
Why?
|
| Boston | 1 | 2021 | 9310 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2019 | 3024 | 0.080 |
Why?
|
| DNA Mismatch Repair | 2 | 2021 | 426 | 0.080 |
Why?
|
| Male | 15 | 2022 | 349776 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5388 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4440 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3439 | 0.070 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2016 | 1052 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 479 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2575 | 0.070 |
Why?
|
| Protein Binding | 3 | 2014 | 9377 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 4463 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6750 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1377 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77410 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1707 | 0.070 |
Why?
|
| Neurons | 3 | 2014 | 9336 | 0.070 |
Why?
|
| Female | 13 | 2022 | 380020 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15067 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 3591 | 0.060 |
Why?
|
| Mice | 9 | 2020 | 81154 | 0.060 |
Why?
|
| Geniculate Ganglion | 1 | 2023 | 8 | 0.060 |
Why?
|
| Seizures | 1 | 2016 | 2850 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3706 | 0.060 |
Why?
|
| Zinc Fingers | 2 | 2016 | 583 | 0.050 |
Why?
|
| E-Box Elements | 2 | 2014 | 21 | 0.050 |
Why?
|
| Middle Aged | 7 | 2023 | 213241 | 0.050 |
Why?
|
| Binding Sites | 4 | 2014 | 6111 | 0.050 |
Why?
|
| Cell Line | 2 | 2013 | 15993 | 0.050 |
Why?
|
| Animals | 10 | 2022 | 168660 | 0.050 |
Why?
|
| Facial Nerve | 1 | 2023 | 271 | 0.050 |
Why?
|
| Genome | 2 | 2021 | 1806 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 376 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 63042 | 0.040 |
Why?
|
| DNA | 1 | 2013 | 7295 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 326 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 9239 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2429 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2023 | 1524 | 0.040 |
Why?
|
| Homozygote | 1 | 2023 | 1787 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2914 | 0.040 |
Why?
|
| Palate, Hard | 1 | 2018 | 57 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 634 | 0.040 |
Why?
|
| Methylation | 1 | 2020 | 1104 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 799 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 18107 | 0.040 |
Why?
|
| Aged | 5 | 2023 | 163178 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57744 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Polymers | 1 | 2023 | 1621 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 2649 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2020 | 1263 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.030 |
Why?
|
| Lysine | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 871 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2013 | 1702 | 0.030 |
Why?
|
| Documentation | 1 | 2021 | 871 | 0.030 |
Why?
|
| Electroporation | 1 | 2016 | 251 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3268 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 21824 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2039 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1851 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2013 | 80 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2020 | 3585 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 397 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 423 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 4183 | 0.030 |
Why?
|
| Chickens | 1 | 2014 | 864 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2009 | 1344 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3547 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2009 | 7880 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11478 | 0.030 |
Why?
|
| Cause of Death | 1 | 2021 | 3580 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6539 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1783 | 0.020 |
Why?
|
| Body Patterning | 1 | 2014 | 629 | 0.020 |
Why?
|
| Stem Cells | 2 | 2016 | 3566 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1952 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 31 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2503 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3583 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 2891 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10251 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 300 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1970 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 894 | 0.020 |
Why?
|
| Vertebrates | 1 | 2008 | 228 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.020 |
Why?
|
| Genome, Human | 1 | 2020 | 4418 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3476 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7908 | 0.020 |
Why?
|
| Pyridines | 1 | 2018 | 2827 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8337 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5714 | 0.020 |
Why?
|
| Retina | 1 | 2016 | 2612 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13273 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 1202 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3504 | 0.010 |
Why?
|
| Epithelium | 1 | 2008 | 1679 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6976 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1120 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16361 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5532 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2016 | 6061 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12954 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14563 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3492 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 19232 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20121 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 24250 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 23398 | 0.000 |
Why?
|